Bioactivity modulation of bioactive materials in view of their application in osteoporotic patients

被引:13
作者
Belmonte, MM
De Benedittis, A
Muzzarelli, RAA
Mengucci, P
Biagini, G
Gandolfi, MG
Zucchini, C
Krajewski, A
Ravaglioli, A
Roncari, E
Fini, M
Giardino, R
机构
[1] Univ Ancona, Sch Med, Ctr Innovat Biomat, CIBAD, I-60020 Ancona, Italy
[2] Univ Bologna, Inst Histol & Embryol, I-40126 Bologna, Italy
[3] Italian Natl Res Council, CNR, Inst Technol Res Ceram, I-48018 Faenza, RA, Italy
[4] Univ Bologna, Putti Rizzoli Orthopaed Inst, Res Inst Codivilla, Dept Expt Surg, I-40136 Bologna, Italy
关键词
D O I
10.1023/A:1008827619290
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The application of bioactive ceramic coatings to prostheses confers strength to a material (ceramic or biological glass) that exerts beneficial effects on bone-tissue growth but that itself lacks the toughness and stability required of an implant device. The rate of bioactivity is related to the chemical reactivity of the material and causes interface dissolution, precipitation and ion-exchange reactions. Ceramics may differ in sintering temperature and thus exhibit differences in their in vitro dissolution features and in vivo performance. To test these effects, in vitro and in vivo studies were carried out on two biocompatible biological glasses and a ceramic of proven bioactivity in view of their potential utilization as covering materials. In addition, a modified chitosan was adsorbed on the surface of a series of hydroxyapatite (HA) samples. Human fibroblasts and/or osteoblasts were used for the in vitro tests, and normal (INT) and osteoporotic (OVX) rats, normal rabbits and sheep for the in vivo studies. Similar chemical changes were observed in both glasses, suggesting that these materials underwent modifications directly dependent on their biological environment. The in vivo tests point to the possibility of improving the bioactivity of ceramic substrates with chitosan. However, the different behaviour of the materials in vitro and in vivo suggests that these tests should be conducted in parallel.
引用
收藏
页码:485 / 492
页数:8
相关论文
共 18 条
[1]  
BELMONTE MM, 1997, CARBOHYDRATES EUROPE, V19, P30
[2]   Ultrastructural study of degradation of calcium phosphate ceramic by human monocytes and modulation of this activity by HILDA/LIF cytokine [J].
Benahmed, MD ;
Heymann, D ;
Berreur, M ;
Cottrel, M ;
Godard, A ;
Daculsi, G ;
Pradal, G .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1996, 44 (10) :1131-1140
[3]  
BRUSHINSKI DA, 1994, J BONE MINER RES, V9, P213
[4]  
Daculsi G, 1996, J BIOMED MATER RES, V31, P495, DOI 10.1002/(SICI)1097-4636(199608)31:4<495::AID-JBM9>3.0.CO
[5]  
2-G
[6]   FORMATION OF A CALCIUM PHOSPHATE-RICH LAYER ON ABSORBABLE CALCIUM-CARBONATE BONE-GRAFT SUBSTITUTES [J].
DAMIEN, CJ ;
RICCI, JL ;
CHRISTEL, P ;
ALEXANDER, H ;
PATAT, JL .
CALCIFIED TISSUE INTERNATIONAL, 1994, 55 (02) :151-158
[7]  
DUCHEYNE P, 1992, CLIN ORTHOP RELAT R, P102
[8]  
Kitsugi T, 1996, J BIOMED MATER RES, V30, P261, DOI 10.1002/(SICI)1097-4636(199602)30:2<261::AID-JBM17>3.0.CO
[9]  
2-P
[10]   Spectrometric study of the thermal evolution of mechanochemically prepared hydroxyapatite-based powders [J].
Krajewski, A ;
Celotti, G ;
Ravaglioli, A ;
Toriyama, M .
CRYSTAL RESEARCH AND TECHNOLOGY, 1996, 31 (05) :637-646